Skip to content

A comparative clinical study of prajasthapanamahakashaya granules and jeevaniyamahakashaya granules in prevention of abortion

A Randomized comparative clinical study of prajasthapanamahakashaya granules and jeevaniyamahakashaya granules in prevention of garbhasrav (early pregnancy loss) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077379
Enrollment
80
Registered
2024-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O090- Supervision of pregnancy with history of infertility

Interventions

None listed

Sponsors

DR ANJALI JAIN
Lead Sponsor
Prof B Pushpalatha
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Married female 21-40 years age group with positive urine pregnancy test will be taken into study between 4-10 weeks of pregnancy with having history of any following conditions: One or more spontaneous abortion Elderly primigravida Pregnancy after Infertility H/O Intra Uterine fetal death Previous preterm birth Choriodecidual haemorrhage in present pregnancy

Exclusion criteria

Exclusion criteria: Patient with severe systemic disease like cardiovascular complications, uncontrolled diabetes mellitus, hematological disorders, hyperthyroidism, Urinary tract infection etc. Pregnancy with carcinoma, large ovarian cyst, large uterine fibroid, uterine prolapse. Pregnancy with history of incompetent OS & congenital uterine malformations. Pregnant female with history of previous congenital malformed child. Sexually transmitted diseases like VDRL, HIV, HbsAg and HCV will be excluded. Pregnancy with TORCH IgM Positive Cases.

Design outcomes

Primary

MeasureTime frame
Continuation of Pregnancy, growth & development of fetus up to 20 weeksTimepoint: 2 months

Secondary

MeasureTime frame
Changes in the minor ailments of pregnancy. Timepoint: 2 months

Countries

India

Contacts

Public ContactDr Anjali Jain

National Institute of Ayurveda(De Novo) Jaipur

anjalijain1807@gmail.com8440836606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026